search
for
 About Bioline  All Journals  Testimonials  Membership  News


Neurology India
Medknow Publications on behalf of the Neurological Society of India
ISSN: 0028-3886 EISSN: 1998-4022
Vol. 50, Num. 2, 2002, pp. 231

Neurology India, Vol. 50, No. 2, June, 2002, pp. 231

Treatment of Trigeminal Neuralgia : Letter to Editor

H.N. Ranganath

Senior Consulting Neurologist, Ragavs Diagnostic and Research Centre P. Ltd., Sri Shapur Plaza, No. 43, 27th Cross, 4th Block West, Jayanagar, Bangalore - 560 011, India.

Code Number: ni02072

Trigeminal neuralgia is well known clinical entity involving a side of the face upto vertex. Many drug therapies like carbamazapine, clonazepan, phenytoin, baclofen have been used for over few decades with variable response. Posterior fossa microsurgery has also been tried.1 Clobazam a newer anticonvulsant was used successfully in trigeminal neuralgia, in a 52 year male, who was symptomatic for over 2 years with little response to phenytoin and carbamazapine. Clobazam was used in a dose of 5mg TDS with 50% reduction of frequency and duration. There was 100% recovery with 10 mg TDS, which was attained in 72 hrs. Use of clobazam can be recommeded in cases of trigeminal neuralgia, not responding to rountine medication.

Fig. 1a, Fig 1b

References

  1. Admas CBT, Kaye AH, Teddy PJ : The treatment of trigeminal neuralgia by posterior fossa microsurgery. J Neurol Neurosurg Psychiatry1982; 45 : 1020.

Copyright 2002 - Neurology India. Also available online at http://www.neurologyindia.com


The following images related to this document are available:

Photo images

[ni02072f1b.jpg] [ni02072f1a.jpg]
Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil